Johannes M et al found that interference of CXCL12 and CXCR4 could functionally interfered with MM chemotaxis to the bone marrow (BM), which led to the resensitization of MM cells to drugs by reversing the CAM-DR in MM [36]. The gene discussed is CXCL12; the disease is Miyoshi myopathy.